Zobrazeno 1 - 10
of 29
pro vyhledávání: '"lymph node metastasi"'
Autor:
Tofanelli, Margherita, Rigo, Stefania, Polesel, Jerry, Zanconati, Fabrizio, Bonazza, Deborah, Marcuzzo, Alberto Vito, Gardenal, Nicoletta, Boscolo-Rizzo, Paolo, Tirelli, Giancarlo
Cystic masses of the lateral neck are mostly benign. However, the incidence of metastatic squamous cell carcinoma (SCC) in cervical cystic masses initially diagnosed as benign is quite high in patients older than 40 years. The aim of this study was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa3534fa50169ad6bad20d308005b8af
https://hdl.handle.net/11368/3030380
https://hdl.handle.net/11368/3030380
Autor:
Alice Zamagni, Mattia Bonetti, Milly Buwenge, Gabriella Macchia, Francesco Deodato, Savino Cilla, Erika Galietta, Lidia Strigari, Francesco Cellini, Luca Tagliaferri, Silvia Cammelli, Alessio Giuseppe Morganti
Androgen deprivation therapy (ADT) is the standard treatment of metastatic prostate cancer (PCa). However, metastases-directed therapies can delay the initiation or switch of systemic treatments and allow local control (LC) and prolonged progression-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f51820779487ebcb3e0cd6249b301048
https://hdl.handle.net/11585/906046
https://hdl.handle.net/11585/906046
Autor:
Paola M.V. Rancoita, Laetitia Lacroix, Catherine Sautès-Fridman, Wolf H. Fridman, Massimo Freschi, Etienne Becht, Yann Vano, Alberto Briganti, Claudio Doglioni, Roberta Lucianò, Nicola Fossati, Matteo Bellone, Julien Calderaro, Francesco Montorsi, Tiffany Guédet, Florent Petitprez
Publikováno v:
European Urology Focus. 5:192-196
Prostate cancer (PCa) patients with lymph node invasion at radical prostatectomy are at higher risk of tumor recurrence and receive immediate androgen deprivation therapy (ADT). While approximately 30% of these patients do not experience recurrence,
Publikováno v:
National Journal of Medical Research, Vol 3, Iss 04 (2013)
Invasive ductal carcinoma, also known as Infiltrating Ductal Carcinoma (IDC) is the most common form of breast cancer. IDC starts in the breast's milk ducts and invades the surrounding breast stroma. Breast cancer usually present as a: swelling of al
Externí odkaz:
https://doaj.org/article/1076a055d72d4fbb8ab2b348c0fe23a3
Autor:
Mithat Gönen, Pierre I. Karakiewicz, Mohammad Abufaraj, Malte Rieken, Romain Mathieu, Alberto Briganti, Christian Seitz, Morgan Rouprê, Veronika Seebacher, Luis A. Kluth, Alexander Bachmann, Shahrokh F. Shariat, Beat Foerster
Publikováno v:
Clin Genitourin Cancer
Using a population-based cohort, data from 50,598 patients treated with radical prostatectomy and pelvic lymph node dissection were used to externally validate our pathologic nodal staging score model. This model allows for quantification of the like
Autor:
Giovanni Scambia, Ettore Capoluongo, Anna Fagotti, M De Bonis, Francesca Moro, Maria Teresa Giudice, F Davià, Carmine Conte, Matteo Bruno, Valerio Gallotta, Gianfranco Zannoni, Gabriella Ferrandina
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 46(7)
Objective This study is aimed to analyze the clinical outcome of recurrent ovarian cancer patients bearing isolated lymph-node recurrence (ILNR) who underwent salvage lymphadenectomy (SL). The prognostic role of clinicopathological variables and the
Autor:
Andrea Salonia, Andrea Necchi, Francesco Montorsi, F. Ripa, Paolo Capogrosso, Alessandro Larcher, Fabio Muttin, Alberto Briganti, Francesco Cianflone, Umberto Capitanio, Roberto Bertini, Alessandro Nini
Publikováno v:
Urologic oncology. 37(4)
Background: The role of lymph node dissection (LND) during nephrectomy for renal cell carcinoma (RCC) is controversial. We looked at the clinical usefulness of performing LND to stratify the risk of patients with RCC and select candidates for systemi
Autor:
Thenappan Chandrasekar, Siamak Daneshmand, Martin Spahn, Christopher P. Evans, Shahrokh F. Shariat, Juan Palou, Cesar D. Vera-Donoso, James M. McKiernan, Francesco Montorsi, Richard Zigeuner, Raj S. Pruthi, Viraj A. Master, Adam Lorentz, Paolo Gontero, Oscar Rodriguez-Faba, Giacomo Novara, Paul Russo, Douglas S. Scherr, Carlo Terrone, Sascha Pahernik, Axel Haferkamp, Gaetano Ciancio, Juan Ignacio Martínez-Salamanca, Javier Carrascosa González, Estefanía Linares Espinós, John A. Libertino, William C. Huang, Markus Hohenfellner, Derya Tilki, Umberto Capitanio
Publikováno v:
Urol Oncol
Urologic oncology, vol 36, iss 2
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Urologic oncology, vol 36, iss 2
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Objectives: To study the effect of lymph node dissection (LND) at the time of nephrectomy and tumor thrombectomy on oncological outcomes in patients with renal cell carcinoma (RCC) and tumor thrombus. Patients and methods: The records of 1,978 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::463d424900f50ce436848abcb6d5b6bb
http://hdl.handle.net/11577/3281437
http://hdl.handle.net/11577/3281437
Autor:
Damiano Stefanello, Giovanni Tortorella, Laura Marconato, Maria Elisabetta Vasconi, Joaquim Henriques, Roberta Ferrari, Silvia L. Benali, Emanuela Maria Morello, Gerry Polton, Silvia Sabattini, Raffaella Bergottini, Maurizio Annoni
Lymph node (LN) metastasis in canine cutaneous mast cell tumours (cMCTs) is a well-known negative prognostic factor. The role of lymphadenectomy in the treatment of stage II disease remains controversial because of its uncertain therapeutic benefit.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f171d334288e03cb305780b334ab7540
http://hdl.handle.net/2318/1686948
http://hdl.handle.net/2318/1686948
Autor:
Maria Domenica Castellone, Serena Bonin, Giancarlo Vecchio, Alessia Parascandolo, Nobuo Tsuchida, Giorgio Stanta, Renzo Barbazza, Cinzia Aversa
Publikováno v:
Oncotarget
// Serena Bonin 1, * , Alessia Parascandolo 2, * , Cinzia Aversa 1 , Renzo Barbazza 1 , Nobuo Tsuchida 3 , Maria Domenica Castellone 4 , Giorgio Stanta 1 and Giancarlo Vecchio 5, 6, 7 1 Dipartimento di Scienze Mediche, Universita di Trieste-Cattinara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b631fee2be4de33d42480267bb00fe
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=24445
http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=24445